Jesus Abraham Simón-Campos

4PUBLICATIONS
47CO-AUTHORS
Infectious diseasesNanomedicinePredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2025
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang

|Jun 27, 2025
Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine.

Constantino López-Macías, Martha Torres, Brenda Armenta-Copca

|Apr 10, 2024
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.

Jennifer Hammond, Robert J Fountaine, Carla Yunis

|May 17, 2023
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.

Jay Tuttle, Edit Drescher, Jesus Abraham Simón-Campos

Pageof 1